You may be eligible for a clinical research study being conducted to test the safety and effectiveness of an
investigational medication that may help to reduce the occurrence of major CVD events, such as heart attacks and strokes, for patients with, or at risk for CVD, who are also statin intolerant.
To qualify you must:
Qualified participants will receive all study medication and study-related care from a dedicated team of medical staff at no cost.
Health insurance is not required to participate.